این سایت در حال حاضر پشتیبانی نمی شود و امکان دارد داده های نشریات بروز نباشند
صفحه اصلی
درباره پایگاه
فهرست سامانه ها
الزامات سامانه ها
فهرست سازمانی
تماس با ما
JCR 2016
جستجوی مقالات
شنبه 24 آبان 1404
فصلنامه علمی پژوهشی گیاهان دارویی
، جلد ۳، شماره ۵۵، صفحات ۹۵-۱۰۴
عنوان فارسی
چکیده فارسی مقاله
کلیدواژههای فارسی مقاله
عنوان انگلیسی
Effects of Rosa canina L. Fruit on Glycemia and Lipid Profile in Type 2 Diabetic Patients: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
چکیده انگلیسی مقاله
Background: Rosa canina L. (rose hip) has been traditionally used to treat diabetes mellitus in Iran. However, no scientific human study has determined its efficacy in diabetic patients. Objective: This study was conducted to evaluate the efficacy and safety of R. canina fruit aqueous extract in type 2 diabetic patients. Methods: Sixty patients with type 2 diabetes, aged 35 - 60 years with fasting blood glucose levels between 130 to 200 mg/dL and HbA1c between 7 - 9% despite using conventional oral hypoglycemic drugs were divided randomly to two groups. Two groups of 25 and 23 patients completing the trial received 750 mg R. canina fruit extract and 750 mg toast powder as placebo two times a day respectively for three months. Fasting blood glucose (FBG) and glycosylated hemoglobin (HbA1c) as primary outcomes and postprandial blood glucose (PBG), lipid profile and hepatic and renal function tests as secondary outcomes were determined at baseline and at endpoint of treatment. The patients were asked to note down any gastrointestinal or other side effects during the study. Results: The FBG level decreased significantly (P = 0.002) in R. canina group after 3 months compared to the baseline. In addition total cholesterol/HDL-C was significantly (P = 0.02) decreased in the R. canina group compared to the baseline. Other blood parameters were not significantly changed during the study compared with placebo and baseline. No serious side effects were reported in both groups during the study. Conclusion: Rosa canina 3-month administration to type 2 diabetic patients may reduce fasting blood glucose and total cholesterol/HDL-C without any side effect.
کلیدواژههای انگلیسی مقاله
نویسندگان مقاله
f هاشم دباغیان | f hashem dabaghian
research institute for islamic and complementary medicine, iran university of medical sciences, tehran iran
سازمان اصلی تایید شده
: دانشگاه علوم پزشکی ایران (Iran university of medical sciences)
m عبداللهی فرد | m abdollahifard
research institute for islamic and complementary medicine, iran university of medical sciences, tehran iran
سازمان اصلی تایید شده
: دانشگاه علوم پزشکی ایران (Iran university of medical sciences)
f خلیقی سیگارودی | f khalighi sigarudi
omid hospital, abhar, zanjan, iran
m تقوی شیرازی | m taghavi shirazi
omid hospital, abhar, zanjan, iran
a شجاعی | a shojaee
research institute for islamic and complementary medicine, iran university of medical sciences, tehran iran
سازمان اصلی تایید شده
: دانشگاه علوم پزشکی ایران (Iran university of medical sciences)
z ثابت | z sabet
research institute for endocrine science, shahid beheshti university of medical sciences, tehran, iran
سازمان اصلی تایید شده
: دانشگاه علوم پزشکی شهید بهشتی (Shahid beheshti university of medical sciences)
h فلاح حسینی | h fallah huseini
research institute for endocrine science, shahid beheshti university of medical sciences, tehran, iran
سازمان اصلی تایید شده
: دانشگاه علوم پزشکی شهید بهشتی (Shahid beheshti university of medical sciences)
نشانی اینترنتی
http://www.jmp.ir/browse.php?a_code=A-10-90-22&slc_lang=en&sid=fa
فایل مقاله
فایلی برای مقاله ذخیره نشده است
کد مقاله (doi)
زبان مقاله منتشر شده
en
موضوعات مقاله منتشر شده
نوع مقاله منتشر شده
1
برگشت به:
صفحه اول پایگاه
|
نسخه مرتبط
|
نشریه مرتبط
|
فهرست نشریات